Mistarz Cecily 4

4 · RAYMOND JAMES FINANCIAL INC · Filed Feb 23, 2026

AI-generated summary of this filing

Updated Feb 23, 2026

RJF Director Cecily Mistarz Receives RSU/DRSU Awards

What Happened

Cecily Mistarz, a director of Raymond James Financial, received a mix of Deferred Restricted Stock Units (DRSUs) and Restricted Stock Units (RSUs) as board compensation on February 19, 2026. The filing shows grants totaling 1,799 units (1,303 DRSUs + 248 RSUs + 248 RSUs to subsidiary boards).
The filing also reports conversions/vestings of previously awarded RSUs (entries totalling 1,753 units: 1,253 + 250 + 250). All transactions were reported at $0.00 per share (awards/vests/conversions, not open-market purchases or sales).

Key Details

Transaction date: February 19, 2026. Filing date: February 23, 2026 (timely).
Reported amounts: Grants = 1,799 RSU/DRSU units; Vest/Conversions = 1,753 units. All at $0.00 (award/vesting/conversion).
Shares owned after transaction: Not disclosed in the excerpt provided.
Footnotes of note:
- F1/F2: DRSUs convert one-for-one to common shares upon vesting and include cash in lieu of dividends; settlement of DRSUs has been irrevocably elected to be deferred until the second anniversary of the vest date.
- F3–F5: RSUs represent contingent rights to receive one share plus accrued cash-in-lieu when they vest; certain awards were scheduled to vest at the next annual meeting (or by Mar 15, 2027) and some awards vested in accordance with their terms.
Transaction codes: A = award/grant; M = exercise/conversion of a derivative (here, conversion/vesting of RSUs/DRSUs).

Context

These entries reflect routine director compensation and vesting/settlement mechanics (awards converting to shares and deferred settlement), not open-market buying or selling. Because settlement of DRSUs is deferred by election, no immediate receipt of tradable shares or cash sale proceeds is indicated. This type of insider filing documents compensation and ordinary vesting events rather than active investment decisions.

Form 4

Period: 2026-02-19

Director

Transactions

Award
Common Stock
[F1][F2]
2026-02-19+1,303→ 2,489 total
Exercise/Conversion
Common Stock
[F3][F2]
2026-02-19+1,253→ 3,742 total
Exercise/Conversion
Common Stock
[F3][F2]
2026-02-19+250→ 3,992 total
Exercise/Conversion
Common Stock
[F3][F2]
2026-02-19+250→ 4,242 total
Award
Restricted Stock Units
[F3][F4]
2026-02-19+248→ 2,001 total
→ Common Stock (248 underlying)
Award
Restricted Stock Units
[F3][F4]
2026-02-19+248→ 2,249 total
→ Common Stock (248 underlying)
Exercise/Conversion
Restricted Stock Units
[F3][F5]
2026-02-19−250→ 1,999 total
→ Common Stock (250 underlying)
Exercise/Conversion
Restricted Stock Units
[F3][F5]
2026-02-19−250→ 1,749 total
→ Common Stock (250 underlying)
Exercise/Conversion
Restricted Stock Units
[F3][F5]
2026-02-19−1,253→ 496 total
→ Common Stock (1,253 underlying)

Footnotes (5)

[F1]Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the second anniversary of the vest date.
[F2]Includes DRSUs.
[F3]Each Restricted Stock Unit (RSU) represents a contingent right to receive, upon vesting of the award: (i) one share of common stock, and (ii) accrued cash in lieu of dividends.
[F4]The award will vest at the date of the next succeeding annual shareholders meeting, but no later than March 15, 2027.
[F5]The award vested in accordance with its terms, which provided for vesting at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant.

Signature

/s/ Cecily Mistarz by Jonathan J. Doyle as Attorney-in-Fact|2026-02-23

1 file